Switch theme
Sign up to access all valuation multiples
Suraksha Diagnostic Ltd offers a one-stop integrated solution for pathology and radiology testing, and medical consultation services to its customers through its extensive operational network, consisting of its flagship central reference laboratory, approximately 8 satellite laboratories, and 215 customer touchpoints which include 49 diagnostic centres, and 166 sample collection centres across the states of West Bengal, Bihar, Assam, and Meghalaya.
2005
1.5K+
LTM Revenue $29.7M
LTM EBITDA $10.0M
$169M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Suraksha Diagnostics has a last 12-month revenue of $29.7M and a last 12-month EBITDA of $10.0M.
In the most recent fiscal year, Suraksha Diagnostics achieved revenue of $25.4M and an EBITDA of $8.5M.
Suraksha Diagnostics expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Suraksha Diagnostics valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $22.1M | $25.4M | XXX | XXX | XXX |
| Gross Profit | $18.9M | $18.9M | XXX | XXX | XXX |
| Gross Margin | 86% | 74% | XXX | XXX | XXX |
| EBITDA | $5.5M | $8.5M | XXX | XXX | XXX |
| EBITDA Margin | 25% | 33% | XXX | XXX | XXX |
| Net Profit | $2.4M | $0.8M | XXX | XXX | XXX |
| Net Margin | 11% | 3% | XXX | XXX | XXX |
| Net Debt | $1.8M | $1.4M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Suraksha Diagnostics's stock price is INR 275 (or $3).
Suraksha Diagnostics has current market cap of INR 14.3B (or $167M), and EV of INR 14.5B (or $169M).
See Suraksha Diagnostics trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $169M | $167M | XXX | XXX | XXX | XXX | $0.07 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Suraksha Diagnostics has market cap of $167M and EV of $169M.
Suraksha Diagnostics's trades at 5.7x LTM EV/Revenue multiple, and 16.9x LTM EBITDA.
Analysts estimate Suraksha Diagnostics's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Suraksha Diagnostics and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $169M | XXX | XXX | XXX |
| EV/Revenue | 5.9x | XXX | XXX | XXX |
| EV/EBITDA | 17.7x | XXX | XXX | XXX |
| P/E | 47.3x | XXX | XXX | XXX |
| P/E/Growth | 1.8x | XXX | XXX | XXX |
| EV/FCF | 49.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSuraksha Diagnostics's NTM/LTM revenue growth is 16%
Suraksha Diagnostics's revenue per employee for the last fiscal year averaged $17K, while opex per employee averaged $12K for the same period.
Over next 12 months, Suraksha Diagnostics's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Suraksha Diagnostics's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Suraksha Diagnostics and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 15% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 34% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 53% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 50% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $17K | XXX | XXX | XXX | XXX |
| Opex per Employee | $12K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 16% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 69% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Suraksha Diagnostics acquired XXX companies to date.
Last acquisition by Suraksha Diagnostics was XXXXXXXX, XXXXX XXXXX XXXXXX . Suraksha Diagnostics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Suraksha Diagnostics founded? | Suraksha Diagnostics was founded in 2005. |
| Where is Suraksha Diagnostics headquartered? | Suraksha Diagnostics is headquartered in India. |
| How many employees does Suraksha Diagnostics have? | As of today, Suraksha Diagnostics has 1.5K+ employees. |
| Is Suraksha Diagnostics publicy listed? | Yes, Suraksha Diagnostics is a public company listed on NSE. |
| What is the stock symbol of Suraksha Diagnostics? | Suraksha Diagnostics trades under SURAKSHA ticker. |
| When did Suraksha Diagnostics go public? | Suraksha Diagnostics went public in 2024. |
| Who are competitors of Suraksha Diagnostics? | Similar companies to Suraksha Diagnostics include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Suraksha Diagnostics? | Suraksha Diagnostics's current market cap is $167M |
| What is the current revenue of Suraksha Diagnostics? | Suraksha Diagnostics's last 12-month revenue is $29.7M. |
| What is the current EBITDA of Suraksha Diagnostics? | Suraksha Diagnostics's last 12-month EBITDA is $10.0M. |
| What is the current EV/Revenue multiple of Suraksha Diagnostics? | Current revenue multiple of Suraksha Diagnostics is 5.7x. |
| What is the current EV/EBITDA multiple of Suraksha Diagnostics? | Current EBITDA multiple of Suraksha Diagnostics is 16.9x. |
| What is the current revenue growth of Suraksha Diagnostics? | Suraksha Diagnostics revenue growth between 2023 and 2024 was 15%. |
| Is Suraksha Diagnostics profitable? | Yes, Suraksha Diagnostics is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
